Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael Lincoff

Showing results (31-40 of 353) with videos related to

Pageof 36
Sort By:
Interventional Cardiology Clinics|June 6, 2017
Pharmacotherapy During Saphenous Vein Graft InterventionWillis M Wu, A Michael Lincoff
Circulation|April 6, 2006
Is clopidogrel cardiovascular medicine's double-edged sword?Anthony A Bavry, A Michael Lincoff
Current Cardiology Reports|July 1, 2005
Direct thrombin inhibitorsMichael S Chen, A Michael Lincoff
Handbook of Experimental Pharmacology|August 25, 2012
Antiplatelet agents in ischemic heart diseaseChristopher H May, A Michael Lincoff
American Heart Journal|October 27, 2009
Magnitude and consequences of missing the acute infarct-related circumflex arteryAmar Krishnaswamy, A Michael Lincoff, Venu Menon
Circulation|December 15, 2004
Diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa blockade: the triad revisitedW H Wilson Tang, A Michael Lincoff
Future Cardiology|May 15, 2013
Management of the patient with diabetes and coronary artery disease: a contemporary reviewTimothy Raymond, Russell Raymond, A Michael Lincoff
Lancet (London, England)|April 27, 2016
REGULATE-PCI trial--Author's replyA Michael Lincoff, John H Alexander, Roxana Mehran
Critical Pathways in Cardiology|March 11, 2010
The use and limitations of unfractionated heparinAmar Krishnaswamy, A Michael Lincoff, Christopher P Cannon
The New England Journal of Medicine|February 21, 2024
Semaglutide and Cardiovascular Outcomes. ReplyA Michael Lincoff, Donna H Ryan, Sille Esbjerg
Pageof 36

Showing results (31-40 of 353) with videos related to

Sort By:
Pageof 36
Interventional Cardiology Clinics|June 6, 2017
Pharmacotherapy During Saphenous Vein Graft InterventionWillis M Wu, A Michael Lincoff
Circulation|April 6, 2006
Is clopidogrel cardiovascular medicine's double-edged sword?Anthony A Bavry, A Michael Lincoff
Current Cardiology Reports|July 1, 2005
Direct thrombin inhibitorsMichael S Chen, A Michael Lincoff
Handbook of Experimental Pharmacology|August 25, 2012
Antiplatelet agents in ischemic heart diseaseChristopher H May, A Michael Lincoff
American Heart Journal|October 27, 2009
Magnitude and consequences of missing the acute infarct-related circumflex arteryAmar Krishnaswamy, A Michael Lincoff, Venu Menon
Circulation|December 15, 2004
Diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa blockade: the triad revisitedW H Wilson Tang, A Michael Lincoff
Future Cardiology|May 15, 2013
Management of the patient with diabetes and coronary artery disease: a contemporary reviewTimothy Raymond, Russell Raymond, A Michael Lincoff
Lancet (London, England)|April 27, 2016
REGULATE-PCI trial--Author's replyA Michael Lincoff, John H Alexander, Roxana Mehran
Critical Pathways in Cardiology|March 11, 2010
The use and limitations of unfractionated heparinAmar Krishnaswamy, A Michael Lincoff, Christopher P Cannon
The New England Journal of Medicine|February 21, 2024
Semaglutide and Cardiovascular Outcomes. ReplyA Michael Lincoff, Donna H Ryan, Sille Esbjerg
Pageof 36